Status:

COMPLETED

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Lead Sponsor:

Poniard Pharmaceuticals

Conditions:

Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is a Phase II research study that is designed for patients who have small cell lung cancer (SCLC) that is no longer responding to treatment. Patients will receive picoplatin, a new platinum-based...

Detailed Description

Platinum drugs work by binding to DNA and preventing the rapid cell division of tumors. However, many tumors demonstrate a resistance to platinum drugs. Results from preclinical studies indicate that ...

Eligibility Criteria

Inclusion

  • Main inclusion criteria:
  • Diagnosis of small cell lung cancer.
  • Patients must have had one prior chemotherapy regimen which must have included either cisplatin or carboplatin.
  • \[Additional eligibility criteria apply.\]
  • Exclusion Criteria:
  • Prior radiotherapy that included \> 30% of the bone marrow (i.e., the whole of the pelvis or half of the spine).
  • Significant chronic or recent acute gastrointestinal disorder with diarrhea as a major symptom.
  • Significant heart disease.
  • Uncontrolled, untreated, unstable, or symptomatic brain tumors or central nervous system disease.
  • Grade 2+ peripheral neuropathy (a condition caused by damage to the nerves in the peripheral nervous system).
  • \[Additional exclusion criteria apply.\]

Exclusion

    Key Trial Info

    Start Date :

    June 1 2005

    Trial Type :

    INTERVENTIONAL

    End Date :

    March 1 2008

    Estimated Enrollment :

    75 Patients enrolled

    Trial Details

    Trial ID

    NCT00116610

    Start Date

    June 1 2005

    End Date

    March 1 2008

    Last Update

    January 21 2009

    Active Locations (55)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 14 (55 locations)

    1

    Genesis Cancer Center

    Hot Springs, Arkansas, United States, 71913

    2

    Study Site

    Los Angeles, California, United States

    3

    Comprehensive Cancer Center

    Palm Springs, California, United States, 92262

    4

    Eastern Connecticut Hematology/Oncology

    Norwich, Connecticut, United States, 06360